Yazmín Odia, MD, MSc
Assistant Professor of Clinical Neurology
Division of Neuro-Oncology
American Board of Psychiatry and Neurology (Adult Neurology)
Office Locations:710 West 168th StreetNew York, NY 10032
Telephone (for appointments): 212–342–0571
Insurance: 1199, Aetna, CIGNA, Empire BC/BS, Fidelis, HealthPlus/Amerigroup, HIP, Multiplan, Oxford, United Healthcare, Medicaid *Please verify insurance participation with the physician's office when making an appointment.
» Department of Neurology
» Neuro-oncology Division/Brain Tumor Center
» Recent Publications
Dr. Yazmín Odia cares for patients with brain tumors in our Division of Neuro-Oncology. Dr. Odia completed her medical training at the University of Chicago Pritzker School of Medicine, a Master of Science in Clinical Research at the Mayo Graduate School in Rochester, MN, and her neurology residency at the Johns Hopkins Hospitals. Prior to joining Columbia, Dr. Odia served as both clinical and research fellow in Neuro-Oncology and Neurology consultant at the National Institutes of Health (NIH) for 3 years. The NIH is as a referral center for difficult brain tumor cases and, thus, lends her familiarity with managing complications of brain tumor cases. She also has clinical trial and translational research experience through various NIH-funded training grants. Her most recent work includes early phase clinical trials for patients with recurrent gliomas. For an appointment with Dr. Odia, please call 212–342–0571.
Yazmin Odia, M.D. M.Sc. is an assistant professor of Neurology in the Division of Neuro-Oncology. In addition to formal training in biomedical research, she has experience in designing and conducting clinical trials using new molecular targets as well as translational research highlighting molecular and radiographic predictors of response or prognosis based on multidisciplinary collaborations across basic and clinical sciences. Significant correlations between molecular alterations and outcome may in turn yield novel targets for treatment.
Her current research focuses on the potential prognostic and predictive role of cMYC expression in gliomas using retrospective pathologic cohorts. Her recent work highlights the prognostic impact of the interactions between cMYC and mutant IDH1 expression, both of which have been implicated in aberrant metabolism and proliferation in animal and cell models. Her ongoing translational research focuses on assessing whether the genetic, molecular and pathologic profiles of gliomas, particularly cMYC and mutant IDH1 co-expression, predict prognosis and response to therapy as well as correlate to potential radiographic surrogates using MRI-guided surgical biopsies.
Neuro-Oncology diagnosis and management focusing on primary central nervous system (CNS) tumors
As chief resident in the Department of Neurology at Johns Hopkins Hospital in Baltimore, MD, Dr. Odia received both the Jay Slotkin Award for Excellence in Research and the Guy M. McKhann Award for Excellence in Teaching. As a graduate of the Pritzker School of Medicine, The University of Chicago, she also received the Excellence in Neurology and Medicine award as well as Alumni Prize for excellence in research. She received the Chicago Honor Scholar full-tuition scholarship as an undergraduate at the University of Chicago.